Home2096 • HKG
add
Simcere Pharmaceutical Group Ltd
Previous close
$8.73
Day range
$8.71 - $8.95
Year range
$5.08 - $9.06
Market cap
21.78B HKD
Avg Volume
7.59M
P/E ratio
28.28
Dividend yield
1.96%
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.76B | 9.08% |
Operating expense | 1.15B | 11.53% |
Net income | 138.28M | 117.73% |
Net profit margin | 7.85 | 116.25% |
Earnings per share | — | — |
EBITDA | 330.12M | 44.43% |
Effective tax rate | 14.95% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.94B | -3.73% |
Total assets | 11.51B | 6.05% |
Total liabilities | 4.44B | 22.33% |
Total equity | 7.07B | — |
Shares outstanding | 2.47B | — |
Price to book | 3.05 | — |
Return on assets | 6.01% | — |
Return on capital | 8.35% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 138.28M | 117.73% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The Company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
CEO
Founded
1995
Headquarters
Website
Employees
6,584
